LG Energy Solution posts KRW 5.6 trillion in consolidated revenue and KRW 492.2 billion in operating profit in Q2 2025 The company records quarterly operating profit even without North American production incentive, thanks to product mix improvements and enhanced cost efficiency In response to recent policy changes and market demands, the company to focus on ESS… Continue reading LG Energy Solution Releases 2025 Second-Quarter Financial Results
Tag: Financial Results
Leads Biolabs Lists on HKEX, Raising USD 189 Million Through Initial Public Offering
NANJING, China, July 24, 2025 /PRNewswire/ — On 25 July, 2025 (China Time), Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company”) listed on the Main Board of The Stock Exchange of Hong Kong Limited (HKEX) under the stock code “09887”. The clinical-stage biotech company priced its IPO at HKD 35 per share, offering 36.86 million shares (excluding… Continue reading Leads Biolabs Lists on HKEX, Raising USD 189 Million Through Initial Public Offering
Shareholder Alert: The Ademi Firm investigates whether Synovus Financial Corp. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE, July 24, 2025 /PRNewswire/ — The Ademi Firm is investigating Synovus (NYSE: SNV) for possible breaches of fiduciary duty and other violations of law in its transaction with Pinnacle Financial Partners. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no… Continue reading Shareholder Alert: The Ademi Firm investigates whether Synovus Financial Corp. is obtaining a Fair Price for its Public Shareholders
HandsFree Labs and Kizik File Lawsuit Against Skechers for Willful Patent Infringement of Hands-Free Footwear Technologies
SALT LAKE CITY, July 24, 2025 /PRNewswire/ — HandsFree Labs, Inc. (“HFL”), the intellectual property and innovation engine behind Kizik®, the brand that created the hands-free footwear category, announced today it has filed a patent infringement lawsuit against Skechers USA, Inc. in the U.S. District Court for the Eastern District of Texas. As alleged in the… Continue reading HandsFree Labs and Kizik File Lawsuit Against Skechers for Willful Patent Infringement of Hands-Free Footwear Technologies
ProCap BTC LLC and Columbus Circle Capital Corporation I Announce Filing of a Draft Registration Statement on Form S-4 with the SEC
NEW YORK, July 24, 2025 /PRNewswire/ — ProCap BTC LLC (“ProCap BTC”), a company focused on holding bitcoin, educating people about bitcoin and other bitcoin-related activities, and Columbus Circle Capital Corp I (“CCCM”) (Nasdaq: CCCM), a special-purpose acquisition company, announced the recent confidential submission by ProCap Financial, Inc. (“ProCap Financial”) of a draft registration statement… Continue reading ProCap BTC LLC and Columbus Circle Capital Corporation I Announce Filing of a Draft Registration Statement on Form S-4 with the SEC
Discovery Institute Applauds President Trump’s Bold Action on Homelessness
SEATTLE, July 24, 2025 /PRNewswire/ — “This is a decisive step toward dramatically reducing homelessness across the United States,” says Robert Marbut, former Executive Director of the U.S. Interagency Council on Homelessness under both the Trump and Biden administrations, and Senior Fellow with the Institute’s long running Fix Homelessness initiative focused on the root causes of… Continue reading Discovery Institute Applauds President Trump’s Bold Action on Homelessness
NWPX Infrastructure, Inc. to Release Second Quarter 2025 Financial Results on August 7th
Financial results to be released after market close on August 7, 2025 Conference call to begin at 7:00 a.m. PT on August 8, 2025 VANCOUVER, Wash., July 24, 2025 /PRNewswire/ — NWPX Infrastructure, Inc. (NASDAQ: NWPX), a leading manufacturer of water-related infrastructure products, announced today that it intends to release its financial results for the second… Continue reading NWPX Infrastructure, Inc. to Release Second Quarter 2025 Financial Results on August 7th
CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight
The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of rheumatoid arthritis, systemic lupus erythematosus, and other inflammatory conditions is boosting demand for targeted immune-modulating therapies. Additionally, advancements in biologics and monoclonal antibody development are expanding the therapeutic pipeline. LAS VEGAS,… Continue reading CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight
Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs
The European Commission’s Approval of Zenrelia reinforces safety and efficacy and further expands opportunities to treat itchy dogs around the world Launch to begin immediately with product in market before the end of Q3 2025 GREENFIELD, Ind., July 24, 2025 /PRNewswire/ — Elanco Animal Health Incorporated (NYSE: ELAN) announced today that Zenrelia™ (ilunocitinib) has received… Continue reading Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs
Elon Musk on Tesla’s new ‘affordable’ electric car: it’s the Model Y
Elon Musk has finally confirmed that Tesla’s new ‘affordable’ electric car is just going to be the Model Y in a cheaper format. Musk has ended months of speculations and misinformation, which he partly created, about Tesla’s upcoming cheaper electric vehicle model. Since last year, Tesla has guided “launching new affordable models” in the first… Continue reading Elon Musk on Tesla’s new ‘affordable’ electric car: it’s the Model Y